$771 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 76.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXAS | New | EXACT SCIENCES CORP | $66,245,000 | – | 500,000 | +100.0% | 8.59% | – |
| IWM | New | ISHARES TRput | $58,818,000 | – | 300,000 | +100.0% | 7.62% | – |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $57,013,000 | +90.4% | 370,000 | +68.2% | 7.39% | +10.4% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $47,548,000 | +74.9% | 650,000 | +85.7% | 6.16% | +1.4% |
| UNH | New | UNITEDHEALTH GROUP INC | $46,445,000 | – | 132,442 | +100.0% | 6.02% | – |
| HCA | New | HCA HEALTHCARE INC | $46,049,000 | – | 280,000 | +100.0% | 5.97% | – |
| EHC | Sell | ENCOMPASS HEALTH CORP | $41,345,000 | -8.8% | 500,000 | -28.3% | 5.36% | -47.1% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $34,980,000 | +18.8% | 140,000 | +7.7% | 4.53% | -31.1% |
| HAE | New | HAEMONETICS CORP | $32,710,000 | – | 275,453 | +100.0% | 4.24% | – |
| MOH | Buy | MOLINA HEALTHCARE INC | $31,902,000 | +74.3% | 150,000 | +50.0% | 4.14% | +1.1% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $30,380,000 | +310.3% | 900,687 | +200.2% | 3.94% | +137.9% |
| NVRO | Buy | NEVRO CORP | $29,213,000 | +31.1% | 168,761 | +5.5% | 3.79% | -24.0% |
| DXCM | New | DEXCOM INC | $27,729,000 | – | 75,000 | +100.0% | 3.59% | – |
| SGRY | Buy | SURGERY PARTNERS INC | $26,670,000 | +62.4% | 919,338 | +22.6% | 3.46% | -5.8% |
| IQV | Buy | IQVIA HLDGS INC | $25,625,000 | +16.1% | 143,020 | +2.2% | 3.32% | -32.6% |
| GH | GUARDANT HEALTH INC | $21,394,000 | +15.3% | 166,000 | 0.0% | 2.77% | -33.1% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $20,752,000 | +5.1% | 800,000 | -60.0% | 2.69% | -39.0% |
| HRTX | New | HERON THERAPEUTICS INC | $18,309,000 | – | 865,072 | +100.0% | 2.37% | – |
| VCEL | VERICEL CORP | $17,910,000 | +66.7% | 580,000 | 0.0% | 2.32% | -3.4% | |
| CTLT | Sell | CATALENT INC | $16,651,000 | -30.6% | 160,000 | -42.9% | 2.16% | -59.7% |
| CNMD | New | CONMED CORP | $16,612,000 | – | 148,317 | +100.0% | 2.15% | – |
| DVA | Sell | DAVITA INC | $16,436,000 | -12.8% | 140,000 | -36.4% | 2.13% | -49.4% |
| NTRA | New | NATERA INC | $14,928,000 | – | 150,000 | +100.0% | 1.94% | – |
| OMI | New | OWENS & MINOR INC NEW | $12,292,000 | – | 454,419 | +100.0% | 1.59% | – |
| OM | OUTSET MED INC | $8,526,000 | +13.7% | 150,000 | 0.0% | 1.10% | -34.1% | |
| RPRX | ROYALTY PHARMA PLC | $5,005,000 | +19.0% | 100,000 | 0.0% | 0.65% | -31.0% | |
| BLFS | Exit | BIOLIFE SOLUTIONS INC | $0 | – | -150,000 | -100.0% | -0.97% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -100,000 | -100.0% | -1.70% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -70,000 | -100.0% | -2.02% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -150,000 | -100.0% | -2.02% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -303,201 | -100.0% | -3.46% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -60,000 | -100.0% | -3.60% | – |
| INOV | Exit | INOVALON HLDGS INC | $0 | – | -650,000 | -100.0% | -3.84% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -600,000 | -100.0% | -5.12% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -357,833 | -100.0% | -5.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.